EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-MetaanalyseOpen Access · CC BY-NC 4.0

Initial Pharmacological Strategies in People with Early Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis

Jong Han Choi, Bo Kyung Koo, Ye Seul Yang, Se Hee Min, Jong Suk Park, Sang Youl Rhee, Hyun Jung Kim, Min Kyong Moon

Diabetes & Metabolism Journal · 2025

DOI: 10.4093/dmj.2024.0660 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Diabetes & Metabolism Journal, 2025. Verfasst von Jong Han Choi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Se…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Centers for Disease Control & Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 2 diabetes mellitus (T2DM) requires stringent glycemic control from an early stage to prevent complications. The most effective treatment regimen for early T2DM remains unclear. The study aimed to compare the efficacy and safety of monotherapies and combination therapies for early T2DM.

Methods

A systematic review and network meta-analysis were conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Randomized controlled trials focused on glycemic control, body weight, and adverse events were included. The primary outcomes were changes in glycosylated hemoglobin (HbA1c) and odds of achieving the target HbA1c after 6 months.

Results

All combination therapies were more effective than monotherapy. Metformin+glucagon-like peptide-1 receptor agonists (GLP-1RA) (weighted mean difference [WMD] –1.50%; 95% confidence interval [CI] –2.04 to –0.96) and metformin+dipeptidyl peptidase-4 inhibitors (WMD –1.46%; 95% CI, –1.96 to –0.95) were the most effective for change in HbA1c. GLP-1RA and sodium- glucose cotransporter-2 inhibitors led to weight reduction. Apart from the increased risk of hypoglycemia with sulfonylureas, no significant differences in adverse events were observed across regimens.

Conclusion

Early combination therapy effectively improved glycemic control in patients with early T2DM without significantly increasing adverse risks. Future studies should explore new combinations, including potent GLP-1RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Hypoglycemic AgentsHumansDrug Therapy, CombinationGlycated HemoglobinMetforminDipeptidyl-Peptidase IV InhibitorsBlood GlucoseRandomized Controlled Trials as TopicGlucagon-Like Peptide-1 Receptor AgonistsSodium-Glucose Transporter 2 Inhibitors

Stichwörter der Autor:innen

Diabetes mellitus, type 2Drug therapy, combinationGlycemic controlHypoglycemic agents

Substanzen

Hypoglycemic AgentsGlycated HemoglobinMetforminDipeptidyl-Peptidase IV InhibitorsBlood GlucoseGlucagon-Like Peptide-1 Receptor Agonistshemoglobin A1c protein, humanSodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

Förderung

  • Korea Centers for Disease Control & Prevention

Zitieren

APA

Choi, J. H., Koo, B. K., Yang, Y. S., Min, S. H., Park, J. S., Rhee, S. Y., Kim, H. J., & Moon, M. K. (2025). Initial Pharmacological Strategies in People with Early Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2024.0660

Vancouver

Choi JH, Koo BK, Yang YS, Min SH, Park JS, Rhee SY, et al. Initial Pharmacological Strategies in People with Early Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis. Diabetes & Metabolism Journal. 2025. doi:10.4093/dmj.2024.0660

BibTeX
@article{Choi2025,
  author = {Choi, Jong Han and Koo, Bo Kyung and Yang, Ye Seul and Min, Se Hee and Park, Jong Suk and Rhee, Sang Youl and Kim, Hyun Jung and Moon, Min Kyong},
  title = {Initial Pharmacological Strategies in People with Early Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis},
  journal = {Diabetes & Metabolism Journal},
  year = {2025},
  doi = {10.4093/dmj.2024.0660}
}
Kostenlos starten →